nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinapril—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00383	0.00383	CcSEcCtD
Quinapril—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00383	0.00383	CcSEcCtD
Quinapril—Pancreatitis—Methotrexate—ankylosing spondylitis	0.00382	0.00382	CcSEcCtD
Quinapril—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00381	0.00381	CcSEcCtD
Quinapril—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00381	0.00381	CcSEcCtD
Quinapril—Alopecia—Dexamethasone—ankylosing spondylitis	0.00379	0.00379	CcSEcCtD
Quinapril—Alopecia—Betamethasone—ankylosing spondylitis	0.00379	0.00379	CcSEcCtD
Quinapril—Discomfort—Prednisolone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Quinapril—Angioedema—Triamcinolone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Quinapril—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00375	0.00375	CcSEcCtD
Quinapril—Malaise—Triamcinolone—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Quinapril—Malaise—Methylprednisolone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Quinapril—Vertigo—Triamcinolone—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Quinapril—Syncope—Triamcinolone—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Quinapril—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Quinapril—Syncope—Methylprednisolone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Quinapril—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Quinapril—Oedema—Prednisolone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Quinapril—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Quinapril—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Quinapril—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Quinapril—Shock—Prednisolone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Quinapril—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Quinapril—Cough—Triamcinolone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Quinapril—Tachycardia—Prednisolone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Quinapril—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Quinapril—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00353	0.00353	CcSEcCtD
Quinapril—Myalgia—Triamcinolone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Quinapril—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Quinapril—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Quinapril—Eye disorder—Prednisone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Quinapril—Infestation—Methotrexate—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Quinapril—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Quinapril—Depression—Methotrexate—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Quinapril—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Quinapril—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Quinapril—Discomfort—Triamcinolone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Quinapril—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Quinapril—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Quinapril—Renal failure—Methotrexate—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Quinapril—Angioedema—Dexamethasone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Quinapril—Angioedema—Betamethasone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Quinapril—Angiopathy—Prednisone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Quinapril—Immune system disorder—Prednisone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Quinapril—Malaise—Dexamethasone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Quinapril—Malaise—Betamethasone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Quinapril—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Quinapril—Oedema—Triamcinolone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Quinapril—Vertigo—Dexamethasone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Quinapril—Vertigo—Betamethasone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Quinapril—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Quinapril—Syncope—Betamethasone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Quinapril—Syncope—Dexamethasone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Quinapril—Arrhythmia—Prednisone—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Quinapril—Infection—Triamcinolone—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Quinapril—Infection—Methylprednisolone—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Quinapril—Shock—Triamcinolone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Quinapril—Insomnia—Prednisolone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Quinapril—Alopecia—Prednisone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Quinapril—Shock—Methylprednisolone—ankylosing spondylitis	0.00329	0.00329	CcSEcCtD
Quinapril—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00329	0.00329	CcSEcCtD
Quinapril—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Quinapril—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Quinapril—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Quinapril—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Quinapril—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Quinapril—Mental disorder—Prednisone—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Quinapril—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Quinapril—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Quinapril—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Quinapril—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Quinapril—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Quinapril—Myalgia—Dexamethasone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Quinapril—Myalgia—Betamethasone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Quinapril—Discomfort—Betamethasone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Quinapril—Discomfort—Dexamethasone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Quinapril—Hepatitis—Methotrexate—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Quinapril—Pharyngitis—Methotrexate—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Quinapril—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Quinapril—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Quinapril—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Quinapril—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Quinapril—Oedema—Dexamethasone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Quinapril—Oedema—Betamethasone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Quinapril—Insomnia—Triamcinolone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Quinapril—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Quinapril—Infection—Dexamethasone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Quinapril—Infection—Betamethasone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Quinapril—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Quinapril—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Quinapril—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Quinapril—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Quinapril—Shock—Dexamethasone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Quinapril—Shock—Betamethasone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Quinapril—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Quinapril—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Quinapril—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Quinapril—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Quinapril—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Quinapril—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Quinapril—Tachycardia—Betamethasone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Quinapril—Angioedema—Prednisone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Quinapril—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Quinapril—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Quinapril—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Quinapril—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Quinapril—Malaise—Prednisone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Quinapril—Vertigo—Prednisone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Quinapril—Eye disorder—Methotrexate—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Quinapril—Syncope—Prednisone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Quinapril—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Quinapril—Fatigue—Triamcinolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Quinapril—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Quinapril—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Quinapril—Angiopathy—Methotrexate—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Quinapril—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Quinapril—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Quinapril—Arthralgia—Prednisone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Quinapril—Myalgia—Prednisone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Quinapril—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Quinapril—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Quinapril—Alopecia—Methotrexate—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Quinapril—Insomnia—Dexamethasone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Quinapril—Insomnia—Betamethasone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Quinapril—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Quinapril—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Quinapril—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Quinapril—Discomfort—Prednisone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Quinapril—Mental disorder—Methotrexate—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Quinapril—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Quinapril—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Quinapril—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Quinapril—Oedema—Prednisone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Quinapril—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Quinapril—Infection—Prednisone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Quinapril—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Quinapril—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Quinapril—Back pain—Methotrexate—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Quinapril—Fatigue—Dexamethasone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Quinapril—Fatigue—Betamethasone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Quinapril—Shock—Prednisone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Quinapril—Nervous system disorder—Prednisone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Quinapril—Tachycardia—Prednisone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Quinapril—Skin disorder—Prednisone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Quinapril—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Quinapril—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Quinapril—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Quinapril—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Quinapril—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Quinapril—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Quinapril—Malaise—Methotrexate—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Quinapril—Vertigo—Methotrexate—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Quinapril—Dizziness—Prednisolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Quinapril—Asthenia—Triamcinolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Quinapril—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Quinapril—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Quinapril—Asthenia—Methylprednisolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Quinapril—Insomnia—Prednisone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Quinapril—Paraesthesia—Prednisone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Quinapril—Pruritus—Triamcinolone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Quinapril—Cough—Methotrexate—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Quinapril—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Quinapril—Dyspepsia—Prednisone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Quinapril—Chest pain—Methotrexate—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Quinapril—Myalgia—Methotrexate—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Quinapril—Arthralgia—Methotrexate—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Quinapril—Rash—Prednisolone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Quinapril—Dermatitis—Prednisolone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Quinapril—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Quinapril—Fatigue—Prednisone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Quinapril—Headache—Prednisolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Quinapril—Discomfort—Methotrexate—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Quinapril—Constipation—Prednisone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Quinapril—Dizziness—Triamcinolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Quinapril—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Quinapril—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Quinapril—Infection—Methotrexate—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Quinapril—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Quinapril—Asthenia—Dexamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Quinapril—Asthenia—Betamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Quinapril—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Quinapril—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Quinapril—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Quinapril—Nausea—Prednisolone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Quinapril—Pruritus—Dexamethasone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Quinapril—Pruritus—Betamethasone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Quinapril—Skin disorder—Methotrexate—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Quinapril—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Quinapril—Vomiting—Triamcinolone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Quinapril—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Quinapril—Rash—Triamcinolone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Quinapril—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Quinapril—Rash—Methylprednisolone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Quinapril—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Quinapril—Headache—Triamcinolone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Quinapril—Headache—Methylprednisolone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Quinapril—Abdominal pain—Prednisone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Quinapril—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Quinapril—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Quinapril—Dizziness—Dexamethasone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Quinapril—Dizziness—Betamethasone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Quinapril—Insomnia—Methotrexate—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Quinapril—Nausea—Triamcinolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Quinapril—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Quinapril—Nausea—Methylprednisolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Quinapril—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Quinapril—Somnolence—Methotrexate—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Quinapril—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Quinapril—Vomiting—Betamethasone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Quinapril—Vomiting—Dexamethasone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Quinapril—Rash—Betamethasone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Quinapril—Rash—Dexamethasone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Quinapril—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Quinapril—Dermatitis—Betamethasone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Quinapril—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Quinapril—Fatigue—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Quinapril—Headache—Betamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Quinapril—Headache—Dexamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Quinapril—Asthenia—Prednisone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Quinapril—Pruritus—Prednisone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Quinapril—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Quinapril—Diarrhoea—Prednisone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Quinapril—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Quinapril—Nausea—Dexamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Quinapril—Nausea—Betamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Quinapril—Dizziness—Prednisone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Quinapril—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Quinapril—Vomiting—Prednisone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Quinapril—Rash—Prednisone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Quinapril—Dermatitis—Prednisone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Quinapril—Headache—Prednisone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Quinapril—Asthenia—Methotrexate—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Quinapril—Nausea—Prednisone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Quinapril—Pruritus—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Quinapril—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Quinapril—Dizziness—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Quinapril—Vomiting—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Quinapril—Rash—Methotrexate—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Quinapril—Dermatitis—Methotrexate—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Quinapril—Headache—Methotrexate—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Quinapril—Nausea—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
